advertisement

---

Aibo MI 18

Showing records 1 to 18 | Display all abstracts from Aibo MI

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Zhu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Zhao AT
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Moksha L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Di Rosa I
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Salowe R
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Salowe R; Jin F; Jin F
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Vrathasha V; Pham K
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Lee R
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Pham K
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Aibo MI
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Aibo MI
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Aibo MI
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Aibo MI; Lee R
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Halimitabrizi M; Chow C
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Halimitabrizi M; Di Rosa I
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Zhu Y
American Journal of Ophthalmology 2025; 280: 120-129

---

127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
O'Brien JM
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319

---

127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Addis V; Sankar PS; Ying GS; O'Brien JM
American Journal of Ophthalmology 2025; 280: 120-129

---